Tilray (TLRY) stock forecast for 2022. Forecast tables and graphs.

Tilray (TLRY) stock forecast for 2022

Last update: December 5, 2022 (06:13)

Sector: Healthcare

The share price of Tilray, Inc. (TLRY) now

What analysts predict: $5.31

52-week high/low: $9.94 / $2.65

50/200 Day Moving Average: $3.523 / $4.299

This figure corresponds to the average price over the previous 50/200 days. For Tilray stocks, the 50-day moving average is the support level today.

For Tilray stocks, the 200-day moving average is the support level today.

Are you interested in Tilray stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Tilray stock price in 2022. How much will one Tilray share be worth in 2022?

Is it worth taking profit / loss on Tilray stock now or waiting? What are analysts' forecasts for Tilray stock?

We forecast Tilray stock performance using neural networks based on historical data on Tilray stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

The Tilray stock prediction results are shown below and presented as a graph, table and text information.

Tilray stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Tilray analysts is $5.31.

Today 200 Day Moving Average is the support level (4.299 $).

50 Day Moving Average is the support level (3.523 $).

Historical and forecast chart of Tilray stock

The chart below shows the historical price of Tilray stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Tilray stock price can be found in the table below.

Tilray (TLRY) Forecast for 2022

Month Target Pes. Opt. Vol., %

Tilray information and performance

Tilray’s headquarters and main manufacturing facilities are located in Nanaimo, British Columbia, Canada. In 2018, the company completed a successful collection of medical cannabis at the company campus in Portugal.

The R&D Center in Nanaimo covers an area of ​​18,300 square meters. In 2018, the total number of kilogram equivalents sold more than doubled to 6,478 kilograms from 3,024 kilograms in 2017.

76% of Tilray is owned by Privateer Holdings, an American private equity firm that invests in the legal cannabis industry.

The company’s shares have seen a dizzying rise since their public offering (IPO) on NASDAQ in July 2018 at a price of $ 17 per share, with a peak price of $ 234 on September 19. However, at the end of 2018, their growth declined and as of March 29, 2019, the price was $ 65 per share.

Tilray is ranked second by market capitalization among the leading companies in the industry, after Canopy Growth (CGC). Among the main competitors of the company are also Aurora Cannabis (ACB), Cronos Group (CRON).

In its short history as a public company, Tilray has achieved a lot. In 2018, the company made a number of acquisitions and signed a number of partnerships to expand its cannabis production, marketing and research activities.

Tilray Address


Market Capitalization: 2 800 221 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -68 503 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: 11.17

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth


Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.


Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 0.41

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: -0.088

Trailing PE: 11.17

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 1000

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.836

Enterprise Value (EV) /Revenue

EV To EBITDA: -10.37

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 611402000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Tilray price target for 2022 by month

Related stocks from Healthcare sector


All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.